pharma · Influenza, Human · Influenza
Seqirus USA
Seqirus (Australia) Pty Ltd
Seqirus (Australia) Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Influenza, Human, Influenza, Influenza Virus. NovaPharmaNews links 9 clinical program(s), 11 drug profile(s),
Summit, USA HQ
8 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Summit, USA
- Employees
- 8
- Programs
- 9
- Drugs
- 19
- Patents
- 0
Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)
Phase 3 · mab · Influenza Virus
Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) for Influenza Virus is a Phase 3 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code V118_05
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Seqirus (Australia) Pty Ltd
- Phase
- Phase 3
- Modality
- mab
- Indication
- Influenza Virus
- Status
- completed
- Trials
- 1